RESUMO
Hand hygiene (HH) is the paramount measure used to prevent healthcare-associated infections. A repeated cross-sectional study was undertaken with direct observation of the degree of compliance on HH of healthcare personnel during the SARS-CoV-2 pandemic. Between, 2018-2019, 9,083 HH opportunities were considered, and 5,821 in 2020-2022. Chi squared tests were used to identify associations. The crude and adjusted odds ratios were used along with a logistic regression model for statistical analyses. Compliance on HH increased significantly (p < 0.001) from 54.5% (95% CI: 53.5, 55.5) to 70.1% (95% CI: 68.9, 71.2) during the COVID-19 pandemic. This increase was observed in four of the five key moments of HH established by the World Health Organization (WHO) (p < 0.05), except at moment 4. The factors that were significantly and independently associated with compliance were the time period considered, type of healthcare-personnel, attendance at training sessions, knowledge of HH and WHO guidelines, and availability of hand disinfectant alcoholic solution in pocket format. Highest HH compliance occurred during the COVID-19 pandemic, reflecting a positive change in healthcare-personnel's behaviour regarding HH recommendations.
Assuntos
COVID-19 , Fidelidade a Diretrizes , Higiene das Mãos , Pessoal de Saúde , Humanos , COVID-19/prevenção & controle , COVID-19/epidemiologia , Estudos Transversais , Fidelidade a Diretrizes/estatística & dados numéricos , Higiene das Mãos/estatística & dados numéricos , Pessoal de Saúde/estatística & dados numéricos , SARS-CoV-2 , Desinfecção das MãosRESUMO
Influenza is a health problem and vaccination is the most effective measure to prevent it. The objective of this study was to evaluate the impact of the COVID-19 pandemic on vaccination coverage (VC) against influenza in healthcare workers (HCWs). A cross-sectional study was conducted at the Dr. Balmis University General Hospital in the province of Alicante (Spain), in which vaccination data were collected retrospectively. Adverse effects (AEs) were detected via telephone call between 15 and 30 days after vaccination. The existence of significant changes in VC between the different seasons studied was evaluated using Chi square with a statistical significance level of p < 0.05. A total of 8403 HCWs vaccinated throughout the different seasons were studied. The vaccination coverage of HCWs for influenza pre-COVID-19 pandemic (2019/20 season) was 51.9%; increased during the pandemic to 67.9% (2020/21 season) and 65.5% (2021/22 season); and, after the pandemic, it decreased to 42.7% (2022/23 season) (p < 0.05). The most frequent reason for vaccination during the periods evaluated was "self-protection", followed by "protection of patients" and "protection of family members". Of all HCWs evaluated, 26.6% (1460/5493) reported at least one AE. During the COVID-19 pandemic, HCWs' influenza vaccination coverage fluctuated considerably. There has been an increase in VC during the most critical moments of the pandemic, both in the 2020/21 and 2021/22 seasons, which has, subsequently, decreased in the 2022/2023 season, to levels below pre-pandemic (2019/2020 season), which justifies implementing specific measures to recover VC in Spain.
RESUMO
Background: Estimating the global influenza burden in terms of hospitalization and death is important for optimizing prevention policies. Identifying risk factors for mortality allows for the design of strategies tailored to groups at the highest risk. This study aims to (a) describe the clinical characteristics of hospitalizations with a diagnosis of influenza over five flu seasons (2016-2017 to 2020-2021), (b) assess the associated morbidity (hospitalization rates and ICU admissions rate), mortality and cost of influenza hospitalizations in different age groups and (c) analyze the risk factors for mortality. Methods: This retrospective study included all hospital admissions with a diagnosis of influenza in Spain for five influenza seasons. Data were extracted from the Spanish National Surveillance System for Hospital Data from 1 July 2016 to 30 June 2021. We identified cases coded as having influenza as a primary or secondary diagnosis (International Classification of Diseases, 10th revision, J09-J11). The hospitalization rate was calculated relative to the general population. Independent predictors of mortality were identified using multivariable logistic regression. Results: Over the five seasons, there were 127,160 hospitalizations with a diagnosis of influenza. The mean influenza hospitalization rate varied from 5/100,000 in 2020-2021 (COVID-19 pandemic) to 92.9/100,000 in 2017-2018. The proportion of influenza hospitalizations with ICU admission was 7.4% and was highest in people aged 40-59 years (13.9%). The case fatality rate was 5.8% overall and 9.4% in those aged 80 years or older. Median length of stay was 5 days (and 6 days in the oldest age group). In the multivariable analysis, independent risk factors for mortality were male sex (odds ratio [OR] 1.14, 95% confidence interval [95% CI] 1.08-1.20), age (<5 years: OR 1; 5-19 years: OR 2.02, 95%CI 1.17-3.49; 20-39 years: OR 4.11, 95% CI 2.67-6.32; 40-59 years: OR 8.15, 95% CI 5.60-11.87; 60-79 years: OR 15.10, 95% CI 10.44-21.84; ≥80 years: OR 33.41, 95% CI 23.10-48.34), neurological disorder (OR 1.97, 95% CI 1.83-2.11), heart failure (OR 1.85, 95% CI 1.74-1.96), chronic kidney disease (OR 1.33, 95% CI 1.25-1.41), chronic liver disease (OR 2.95, 95% CI 2.68-3.27), cancer (OR 1.85, 95% CI 1.48-2.24), coinfection with SARS-CoV2 (OR 3.17, 95% CI 2.34-4.28), influenza pneumonia (OR 1.76, 95% CI 1.66-1.86) and admission to intensive care (OR 7.81, 95% CI 7.31-8.36). Conclusion: Influenza entails a major public health burden. People aged over 60-and especially those over 80-show the longest hospital stays. Age is also the most significant risk factor for mortality, along with certain associated comorbidities.
Assuntos
Influenza Humana , Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Feminino , Influenza Humana/epidemiologia , Estudos Retrospectivos , Espanha/epidemiologia , Estações do Ano , Pandemias , RNA Viral , Hospitalização , Fatores de RiscoRESUMO
OBJECTIVE: This study aimed to evaluate the effectiveness of SARS-CoV-2 mRNA vaccines in preventing infection and hospitalization among healthcare workers (HCWs) in the Valencian Community (Spain), considering vaccination timing, dose number, and predominant variant. METHODS: A test-negative case-control design estimated vaccine effectiveness against symptomatic disease and hospitalization due to SARS-CoV-2. HCWs who underwent PCR or antigen testing for SARS-CoV-2 from January 2021 to March 2022 were included. Cases had a positive diagnostic test, while controls had negative tests. Adjusted vaccine effectiveness (aVE) was calculated using the formula: aVE = (1 - Odds ratio) × 100. RESULTS: During the Delta variant's predominance, aVE against infection within 12-120 days post-second dose was 64.8 % (BNT162b2) and 59.4 % (mRNA-1273), declining to 21.2 % and 42.2 %, respectively, after 120 days. For the Omicron variant, aVE within 12-120 days post-second dose was 61.1 % (BNT162b2) and 85.1 % (mRNA-1273), decreasing to 36.7 % and 24.9 %, respectively, after 120 days. After a booster dose of mRNA-1273, aVE was 64.0 % (BNT162b2 recipients) and 65.9 % (initial mRNA-1273 recipients). Regardless of variant, aVE for hospitalization prevention after 2 doses was 87.0 % (BNT162b2) and 89.0 % (mRNA-1273). CONCLUSION: The administration of two doses of Moderna-mRNA-1273 against SARS-CoV-2 in HCWs proved to be highly effective in preventing infections and hospitalizations in the first 120 days after the second dose during the predominance of the Omicron variant. The decline in VE after 120 days since the administration of the second dose was significantly restored by the booster dose administration. This increase in VE was greater for the Pfizer vaccine. COVID-19 hospitalization prevention remained stable with both mRNA vaccines throughout the study period.
Assuntos
Vacina BNT162 , Vacinas contra COVID-19 , COVID-19 , Pessoal de Saúde , Hospitalização , Imunização Secundária , SARS-CoV-2 , Eficácia de Vacinas , Humanos , COVID-19/prevenção & controle , COVID-19/epidemiologia , Espanha/epidemiologia , SARS-CoV-2/imunologia , SARS-CoV-2/genética , Masculino , Feminino , Hospitalização/estatística & dados numéricos , Adulto , Pessoa de Meia-Idade , Vacinas contra COVID-19/imunologia , Vacinas contra COVID-19/administração & dosagem , Vacina BNT162/imunologia , Vacina BNT162/administração & dosagem , Estudos de Casos e Controles , Vacina de mRNA-1273 contra 2019-nCoV/imunologia , Vacinação/métodosRESUMO
INTRODUCTION: Influenza poses a significant burden in terms of morbidity and mortality, with vaccination being one of the most effective measures for its prevention. Therefore, the aim of this study is to determine the effectiveness of the influenza vaccine in preventing cases of severe influenza in patients admitted to a tertiary hospital during the 2022/23 season. METHODS: Case-control study. All hospitalised patients with a positive result in an RT-PCR for influenza were included. Those who met the criteria for a severe case (pneumonia, sepsis, multi-organ failure, admission to ICU or exitus) were considered cases. Those who did not meet these criteria were considered controls. Vaccine effectiveness (VE) to prevent severe cases and its 95% confidence interval were calculated. RESULTS: A total of 403 patients were admitted with confirmed influenza. Of these, 98 (24.3%) developed severe influenza. Of the total, 50.6% were men and 47.1% were over 65 years of age. VE adjusted for influenza type, age and certain comorbidities was 40.6% (-21.9 to 71.1). In a segmented analysis, influenza vaccine was effective in preventing severe cases in all categories. It was particularly relevant in the 65+ age group (VEaâ¯=â¯60.9%; -2.0 to 85.0) and in patients with influenza A (VEaâ¯=â¯56.7%; 1.5-80.9). CONCLUSION: Influenza vaccination markedly reduced the occurrence of severe cases of influenza in hospitalised patients, therefore, it remains the main strategy to reduce morbidity and mortality and associated costs.
Assuntos
Vacinas contra Influenza , Influenza Humana , Masculino , Humanos , Feminino , Influenza Humana/epidemiologia , Influenza Humana/prevenção & controle , Estudos de Casos e Controles , Estações do Ano , VacinaçãoRESUMO
Since the beginning of the COVID-19 pandemic in March 2020, the use of masks has been a fundamental pillar for controlling the transmission of SARS-CoV-2 in different areas. Its mandatory nature has been regulated by different regulations, and its effectiveness in reducing the transmission of SARS-CoV-2 and other respiratory viruses has been strongly proven. In this regard, the beneficial impact stands out in healthcare centers where it has been shown to reduce the transmission of respiratory infections, both in patients and healthcare professionals. This document proposes recommendations for the use of masks in health centers at the current time when we find ourselves with an end to the mandatory use of masks in Spain. They are aimed at healthcare professionals, patients and companions/visitors and aim to protect them from acquiring acute respiratory infections as a result of the complex relationships established in the healthcare field.
Desde el inicio de la pandemia de la COVID-19 en marzo de 2020, el uso de la mascarilla ha constituido un pilar fundamental para el control de la transmisión del SARS-CoV-2 en diferentes ámbitos. Su obligatoriedad ha sido regulada por diferentes normativas, y la efectividad de la misma para la reducción de la transmisión del SARS-CoV-2 y de otros virus respiratorios ha sido fuertemente probada. Al respecto, destaca el impacto beneficioso en los centros sanitarios en los que ha demostrado reducir la transmisión de las infecciones respiratorias, tanto en pacientes como en profesionales sanitarios. Este documento plantea una propuesta de recomendaciones para el uso de la mascarilla en los centros sanitarios en el momento actual en el que nos encontramos con un cese de la obligatoriedad de su uso en España. Están dirigidas a profesionales sanitarios, pacientes y acompañantes/visitantes y pretenden protegerles de adquirir infecciones respiratorias agudas como consecuencia de las complejas relaciones establecidas en el ámbito sanitario.
Assuntos
COVID-19 , Infecções Respiratórias , Humanos , Espanha , Pandemias/prevenção & controle , COVID-19/prevenção & controle , SARS-CoV-2RESUMO
Healthcare-associated infections (HAIs) present a global public health challenge, contributing to high morbidity and mortality and substantial economic burdens. Ventilator-associated pneumonia (VAP) ranks as the second most prevalent HAI in intensive care units (ICUs), emphasizing the need for economic analyses in this context. This retrospective cohort study, conducted at the General Hospital of Alicante from 2012 to 2019, aimed to assess additional costs related to VAP by comparing the extended length of stay for infected and non-infected ICU patients undergoing mechanical ventilation (MV) for more than 48 h. Employing propensity score association, 434 VAP patients were compared to an equal number without VAP. The findings indicate a significantly longer mechanical ventilation period for VAP patients (17.40 vs. 8.93 days, p < 0.001), resulting in an extra 13.56 days of stay and an additional cost of EUR 20,965.28 per VAP episode. The study estimated a total cost of EUR 12,348,965.28 for VAP during the study period, underscoring the economic impact of VAP. These findings underscore the urgent need for rigorous infection surveillance, prevention, and control measures to enhance healthcare quality and reduce overall expenditures.
RESUMO
Desde el inicio de la pandemia de la COVID-19 en marzo de 2020, el uso de la mascarilla ha constituido un pilar fundamental para el control de la transmisión del SARS-CoV-2 en diferentes ámbitos. Su obligatoriedad ha sido regulada por diferentes normativas, y la efectividad de la misma para la reducción de la transmisión del SARS-CoV-2 y de otros virus respiratorios ha sido fuertemente probada. Al respecto, destaca el impacto beneficioso en los centros sanitarios en los que ha demostrado reducir la transmisión de las infecciones respiratorias, tanto en pacientes como en profesionales sanitarios. Este documento plantea una propuesta de recomendaciones para el uso de la mascarilla en los centros sanitarios en el momento actual en el que nos encontramos con un cese de la obligatoriedad de su uso en España. Están dirigidas a profesionales sanitarios, pacientes y acompañantes/visitantes y pretenden protegerles de adquirir infecciones respiratorias agudas como consecuencia de las complejas relaciones establecidas en el ámbito sanitario.(AU)
Since the beginning of the COVID-19 pandemic in March 2020, the use of masks has been a fundamental pillar for controlling the transmission of SARS-CoV-2 in different areas. Its mandatory nature has been regulated by different regulations, and its effectiveness in reducing the transmission of SARS-CoV-2 and other respiratory viruses has been strongly proven. In this regard, the beneficial impact stands out in healthcare centers where it has been shown to reduce the transmission of respiratory infections, both in patients and healthcare professionals. This document proposes recommendations for the use of masks in health centers at the current time when we find ourselves with an end to the mandatory use of masks in Spain. They are aimed at healthcare professionals, patients and companions/visitors and aim to protect them from acquiring acute respiratory infections as a result of the complex relationships established in the healthcare field.(AU)
Assuntos
Humanos , Masculino , Feminino , Máscaras , Instalações de Saúde , Prevenção de Doenças , Controle de Doenças Transmissíveis , Infecções Respiratórias/prevenção & controle , /prevenção & controle , Espanha , Saúde Pública , /epidemiologiaRESUMO
Objetivo: Conocer la efectividad de la vacuna BNT162b2 en personal sanitario de un departamento de salud. Método: Estudio de casos y controles con prueba negativa. Se incluyó personal sanitario con sospecha de COVID-19 y personal sanitario que fue contacto estrecho de casos de COVID-19 entre el 25 de enero y el 6 de junio de 2021. Se les realizó prueba de reacción en cadena de la polimerasa (PCR) para SARS-CoV-2; aquellos con PCR positiva fueron considerados casos y aquellos con PCR negativa fueron considerados controles. Se calculó la efectividad vacunal ajustada (EVa) para prevenir casos de COVID-19 y su intervalo de confianza del 95% (IC95%), mediante la fórmula EV = (1 − odds ratio) × 100. Resultados: Se incluyeron 624 profesionales sanitarios; de ellos, 43 (6,9%) casos y 581 (93,1%) controles. La EVa de la pauta completa fue del 96,3% (IC95%: 82,5-99,2) y la de la pauta incompleta del 68,0% (IC95%: 30,0-85,4). Conclusiones: La administración de la pauta completa de vacuna es efectiva para la prevención de casos de COVID-19 en el personal sanitario. (AU)
Objective: To assess the effectiveness of the vaccine against SARS-CoV-2 (BNT162b2) in healthcare personnel of a health department. Method: Test-negative case̶control study. Healthcare personnel with suspected COVID-19 and healthcare personnel close contacts of COVID-19 cases were included between January 27th and June 6 th, 2021. They were PCR tested for SARS-CoV-2; those with positive PCR were considered cases and those with negative PCR were considered controls. The adjusted vaccine effectiveness (aVE) to prevent COVID-19 cases and their 95% confidence interval (95%CI) were calculated using the formula VE = (1 − odds ratio) × 100. Results: 624 healthcare personnel were included, of which 43 (6.9%) were considered cases and 581 (93.8%) controls. The aVE of the complete regimen was 96.3% (95%CI: 82.5̶99.2). The aVE of the incomplete pattern was 68.0% (95%CI: 30.0̶85.4). Conclusions: The administration of the complete pattern of BNT162b2 vaccine against SARS-CoV-2 is effective for the prevention of cases of COVID-19 in healthcare personnel. (AU)
Assuntos
Humanos , Masculino , Feminino , Pandemias , Infecções por Coronavirus/epidemiologia , Vacinação em Massa , Pessoal de Saúde , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave , Estudos de Casos e Controles , Entrevistas como AssuntoRESUMO
Objetivo: Conocer la efectividad de la vacuna de la gripe de la temporada 2018/2019 para la prevención de casos graves de gripe en un hospital terciario. Método: Estudio de casos y controles. Se incluyeron todos los pacientes hospitalizados con gripe confirmada por laboratorio durante la temporada 2018/2019. Los que cumplieron criterios de caso grave de gripe (neumonía, fallo multiorgánico, shock séptico, ingreso en la unidad de cuidados intensivos o muerte) se consideraron caso. Los que no cumplían criterios de gravedad se consideraron controles. Se calculó la efectividad de la vacuna (EV) cruda y ajustada (para prevenir casos graves de gripe), así como su intervalo de confianza del 95%, mediante la fórmula EV = (1 − odds ratio) × 100. Resultados: La efectividad ajustada por grupo de edad y comorbilidad fue del 60,7% (20,5-80,5). En el análisis ajustado y restringido a cada sexo, grupo de edad y presencia de comorbilidad, la vacuna de la gripe tuvo un efecto positivo en todos los grupos y categorías, siendo la efectividad del 55,0% (2,6-79,2) en el grupo de edad de 65 años o más. Conclusiones: La vacunación antigripal redujo la gravedad de la gripe en los pacientes hospitalizados. Estos hallazgos deberían tenerse en cuenta para mejorar las estrategias de vacunación y alcanzar mejores coberturas vacunales en la población de riesgo, con la finalidad no solo de disminuir los casos de gripe, sino también su gravedad. (AU)
Objective: To know the effectiveness of the 2018/2019 flu vaccine for the prevention of severe cases of flu in a tertiary hospital. Method: Case-control study. We included all patients hospitalized with influenza confirmed by laboratory during 2018/2019 season. Those who met the criteria of severe case of influenza (pneumonia, multiorgan failure, septic shock, ICU admission or death) were considered as cases. Non severe cases of influenza were included in the control group. We calculated the effectiveness of the raw and adjusted vaccine (to prevent severe cases of influenza) and its 95% confidence interval using formula VE = (1 − odds ratio) × 100. Results: Effectiveness of flu vaccine adjusted by age group and comorbidities was 60.7% (20.5-80.5). In the analysis adjusted and restricted to each sex, age group and presence of comorbidities, the influenza vaccine had a positive effect in all groups and categories, with effectiveness in the age group 65 years or more being 55.0% (2.6-79.2). Conclusions: Flu vaccination reduced the severity of influenza in hospitalized patients. These findings should be taken into account to improve vaccination strategies and achieve better vaccination coverage in the high-risk population in order not only to decrease flu cases, but also their severity. (AU)
Assuntos
Humanos , Vacinas contra Influenza , Vírus da Influenza B , Vírus da Influenza A Subtipo H3N2 , Estudos de Casos e Controles , Envelhecimento , Estações do AnoRESUMO
Objetivo: Estimar la prevalencia de anticuerpos IgG frente a SARS-CoV-2 en profesionales sanitarios (PS) de un departamento sanitario (DS). Métodos: Estudio de prevalencia. Se determinó la presencia de anticuerpos IgG frente a SARS-CoV-2 en los PS del DS. La determinación se realizó mediante la técnica de ELISA. El trabajo de campo se realizó del 24 de abril de 2020 al 8 de mayo de 2020. Se recogieron edad, sexo, estamento (facultativo, enfermería, etc.) y área de trabajo (atención primaria, urgencias, etc.). Se calculó la prevalencia de anticuerpos IgG frente a SARS-CoV-2 con su intervalo de confianza al 95% (IC95%). Para estudiar la asociación entre las características de los PS y la presencia de IgG se utilizó la prueba de la ji cuadrado y para cuantificar la magnitud de asociación se calculó la odds ratio (IC95%). Resultados: De los 4.813 PS del DS participaron 4.179 (87,1%). De estos, el 73,3% (3.065) eran mujeres y el 26,7% (1.114) hombres. La prevalencia global de presencia de anticuerpos IgG frente a SARS-CoV-2 fue del 6,6% (IC95%: 5,8-7,3). Hubo diferencias estadísticamente significativas según estamento, oscilando del 8,7% (IC95%: 6,9-10,6) en facultativos al 3,2% (IC95%: 1,0-8,0) en otro personal no sanitario. El resto de características no se asociaron de forma significativa a la presencia de anticuerpos frente a SARS-CoV-2. Conclusión: La frecuencia de infección por SARS-CoV-2 en PS es similar a la estimada para la población general en grandes ciudades en España, lo que orienta sobre la efectividad del programa de prevención y control de infecciones dirigido a los profesionales sanitarios en este DS.(AU)
Objective: Estimate IgG antibody prevalence against SARS-CoV-2 in healthcare personnel (HCP) of a healthcare department (HD). Method: Prevalence study. The presence of IgG antibodies against SARS-CoV-2 was determined in HCP of the HD. Enzyme linked immunosorbent assays (ELISA) tests were used. Field work took place from April 24, 2020 to May 8, 2020. The age, sex, occupation (physician, nurse, etc.) and the work area (Primary Care, Emergency Room, etc.) were gathered. The IgG antibody prevalence was then calculated with its 95% confidence interval (95%CI). To study the association between HCP characteristics and the presence IgG the Chi Square test was used, and to study the magnitude of association, the Odds Ratio (95%CI) was calculated. Results: Of the 4813 HCP in the HD, 4179 (87,1%) participated. Of these, 73,3% (3065) were women and 26,7% (1114) men. The global prevalence of IgG antibodies against SARS-CoV-2 was 6,6% (95%CI: 5,8-7,3). There were statistically significant differences depending on the occupation, from 8,7% (95%CI: 6,9-10,6) on medics down to 3,2% (95%CI: 1,0-8,0) on personnel not associated with health care. The other characteristics did not associate significantly to antibody presence against SARS-CoV-2. Conclusion: The SARS-CoV-2 infection frequency in HCP is similar to the estimated in the general population for big cities in Spain. This highlights the effectiveness of the infection control and prevention programme in this healthcare department targeted at healthcare personnel.(AU)
Assuntos
Humanos , Masculino , Feminino , Coronavírus Relacionado à Síndrome Respiratória Aguda Grave , Infecções por Coronavirus/epidemiologia , Betacoronavirus , Pandemias , Pessoal de Saúde , Imunoglobulina G , Ensaio de Imunoadsorção Enzimática , Serviços Preventivos de Saúde , Controle de Infecções , Doenças Transmissíveis , Microbiologia , Estudos Transversais , Interpretação Estatística de DadosRESUMO
OBJETIVO: Describir las secuelas referidas en los casos atendidos por patología no traumática del hombro. Y conocer cómo se asocian con la presencia de secuelas las características sociodemográficas, disponer de conocimientos en prevención de riesgos laborales y los requerimientos ergonómicos del puesto de trabajo. MÉTODOS: Estudio observacional transversal en una población de 345 pacientes atendidos durante un año en las consultas de un centro de atención primaria de salud en Alicante. Mediante la prueba de la Ji-cuadrado se estudiaron las asociaciones entre las secuelas y el resto de variables. RESULTADOS: El 53,9% (n = 186) de los participantes refirieron presentar secuelas derivadas, sobre todo dolor ocasional asociado o no a limitación de la movilidad. Son factores de riesgo: un bajo nivel de estudios, actividades de limpieza y sector industrial, alzar los brazos por encima del hombro y la monotonía en las tareas. Sin embargo, son factores protectores: el sexo masculino, disponer de información sobre los riesgos laborales, equipos de protección individual, existencia de Servicio de Prevención de Riesgos Laborales, evaluación de riesgos, plan de prevención y los reconocimientos médicos periódicos. Conocer los riesgos del puesto se mostró como factor de protección independiente frente al desarrollo de secuelas (Ora = 0,2; IC 95% = 0,1-0,4). Sin embargo, alzar el brazo por encima del hombro, se comporta como factor de riesgo independiente para el desarrollo de secuelas por patología del hombro (Ora = 2,1; IC 95% = 1,0-4,3). CONCLUSIONES: La combinación de estrategias ergonómicas y formativas parecen útiles para la prevención del desarrollo de secuelas a nivel del hombro
OBJECTIVE: To describe the sequelae referred to the cases attended by non-traumatic diseases of the shoulder. To know how sociodemographic characteristics, preventive knowl-edge about the workplace and ergonomic requirements are associated with the presence of sequelae. METHODS: Cross-sectional observational study in a population of 345 patients attended for a year in the consultations of a primary health care center in Alicante. Through the Chi-square test, the associations between the sequels and the rest of the variables were studied. RESULTS: 53.9% (n = 186) of the participants reported having sequelae derived, especially occasional pain associated or not with limitation of joint mobility. They are risk factors: a low level of studies, cleaning activities and industrial sector, raising the arm over the shoulder and the monotony in the workplace. However, they are protective factors: male sex, having information on occupational risks, Personal Protective Equipment, the existence of a Labor Risk Prevention Service, Risk Assessment, Prevention Plan and periodic medical examinations. Knowing the risks of the position was shown as an independent protection factor against the development of secondary sequelae in the shoulder (ORa = 0,2; IC 95% = 0,1-0,4). However, to raise the arm above the shoulder, behaving as an independent risk factor for the development of sequelae due to shoulder pathology (ORa = 2,1; IC95% = 1,0-4,3)
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Doenças Profissionais/prevenção & controle , Lesões do Ombro/prevenção & controle , Ergonomia/métodos , Fatores Socioeconômicos , Estudos TransversaisRESUMO
OBJETIVO: Evaluar la efectividad de un programa de prevención y control de infecciones (PCI) por COVID-19 en los trabajadores sanitarios (TS) del servicio de urgencias de un hospital terciario. MÉTODO: Se recogió el número de casos confirmados de COVID-19 en TS del 2 de marzo al 12 de abril de 2020. Los TS fueron evaluados si presentaban síntomas o en el marco de estudios de contactos. Se recogió: edad, sexo, estamento, área trabajo y motivo contacto. Se comparó si existían diferencias entre los TS del SU y los del resto del Departamento de Salud (DS). RESULTADOS: De los 3.900 TS del DS (279 adscritos al SU), se evaluaron 1.744 TS (92 del SU). Presentaron síntomas 736 (52 del SU); 151 fueron confirmados COVID-19 (9 del SU). Dos casos del SU (22,2%) se atribuyeron a la asistencia sanitaria, y 7 (77,8%) a relaciones sociales en el lugar de trabajo o fuera de este. La prevalencia de TS con COVID-19 en el SU fue de un 3,2% (9/279), y en el resto de TS del 3,9% (142/3621). Entre los TS del SU y del resto del DS no hubo diferencias significativas en la prevalencia de afectados, ni entre los motivos de contacto. CONCLUSIONES: Teniendo en cuenta la prevalencia de TS con COVID-19 del SU respecto al resto del DS, el motivo del contacto de riesgo y su distribución en el tiempo, se puede considerar que el PCI orientado al SU fue efectivo
OBJECTIVE: To evaluate the effectiveness of a coronavirus disease 2019 (COVID-19) prevention and control program for health care workers in a tertiary care hospital emergency department (ED). METHODS: We recorded the number of confirmed COVID-19 workers in the ED on March 2, 2020, and April 12, 2020. Workers were screened if they had symptoms or were traced as contacts. Variables recorded were age, sex, staff position, work area, and reason for contact. We used the χ2 test to compare ED workers to workers in other areas of the health care system. RESULTS: Of the 3900 health care workers (279 in the ED), 1744 cases (92 in the ED) were included for analysis. A total of 736 workers (52 in the ED) had symptoms, and 151 had positive test results (9 from the ED). Two of the infections in the ED workers (22.2%) were attributed to patient contact and 7 (77.8%) to nonwork-related contact either in the workplace or in the community. The prevalence of COVID-19 among ED workers was 3.2% (9/279). The prevalence among other health system workers was 3.9% (142/3621). The differences in COVID-19 prevalencebetween the 2 groups was not significant. Nor was there a significant difference in the reasons for contact with the virus between the 2 groups. CONCLUSION: Based on the prevalence of COVID-19 among ED workers and other health care workers, the reasons for risk of contact with the virus, and the time frame for gathering the data, we conclude that the prevention and control measures in the ED have been effective
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Pandemias/prevenção & controle , Infecções por Coronavirus/prevenção & controle , Serviços Médicos de Emergência/estatística & dados numéricos , Socorristas/estatística & dados numéricos , Resultado do Tratamento , Pneumonia Viral/prevenção & controle , Intervalos de Confiança , Equipamentos de Proteção/normasRESUMO
INTRODUCTION: Bloodstream Infections has become in one of the priorities for the antimicrobial stewardship teams due to their high mortality and morbidity rates. Usually, the first antibiotic treatment for this pathology must be empirical, without microbiology data about the microorganism involved. For this reason, the population studies about the etiology of bacteremia are a key factor to improve the selection of the empirical treatment, because they describe the main microorganisms associated to this pathology in each area, and this data could facilitate the selection of correct antibiotic therapy. MATERIAL AND METHODS: This study describes the etiology of bloodstream infections in the Southeast of Spain. The etiology of bacteremia was analysed by a retrospective review of all age-ranged patients from every public hospital in the Autonomous Community of Valencia (approximately 5,000,000 inhabitants) for five years. RESULTS: A total of 92,097 isolates were obtained, 44.5% of them were coagulase-negative staphylococci. Enterobacteriales was the most prevalent group and an increase in frequency was observed along the time. Streptococcus spp. were the second microorganisms more frequently isolated. Next, the most prevalent were Staphylococcus aureus and Enterococcus spp., both with a stable incidence along the study. Finally, Pseudomonas aeruginosa was the fifth microorganism more frequently solated. CONCLUSIONS: These data constitute a useful tool that can help in the choice of empirical treatment for bloodstream infections, since the knowledge of local epidemiology is key to prescribe a fast and appropriate antibiotic therapy, aspect capital to improve survival
INTRODUCCIÓN: Las bacteriemias se han convertido en una de las prioridades de los Programas de Optimización de uso de Antimicrobianos (PROA) debido a sus altas tasas de morbimortalidad. Normalmente, el tratamiento antibiótico tiene que ser pautado de forma empírica, sin datos del microorganismo implicado. Por esto, los estudios poblacionales sobre la etiología de las bacteriemias son un factor clave para mejorar la elección del tratamiento empírico, ya que describen los principales microorganismos asociados a esta patología en cada área, lo que facilita en gran medida la selección del antibiótico correcto. MATERIAL Y MÉTODOS: Este estudio describe la etiología de las bacteriemias en el sureste de España durante los años 2013-2017. La etología fue analizada de forma retrospectiva estudiando los microorganismos implicados en todas las bacteriemias diagnosticadas en la Comunidad Valenciana (5.000.000 de habitantes). RESULTADOS: Se obtuvieron un total de 92.097 aislados clínicos, de los cuales un 44,5% fueron Staphylococcus coagulasa negativos. Las enterobacterias fueron el grupo más prevalente, su frecuencia se incrementó durante el estudio. Los cocos grampositivos, tipo Streptococcus, fueron los siguientes microorganismos que se aislaron de forma más frecuente, su frecuencia disminuyó a lo largo del periodo estudiado. A continuación, Staphylococcus aureus y Enterococcus spp. les siguieron en prevalencia, manteniéndose sus tasas estables a lo largo del estudio. Por último, el quinto microorganismo más prevalente fue Pseudomonas aeruginosa. CONCLUSIONES: Los datos obtenidos en este estudio constituyen una herramienta que puede facilitar la elección correcta del tratamiento empírico inicial que debe aplicarse en estos procesos
Assuntos
Humanos , Bacteriemia/epidemiologia , Sangue/microbiologia , Hemocultura/métodos , Infecções Bacterianas/epidemiologia , Staphylococcus/isolamento & purificação , Contagem de Colônia Microbiana/métodos , Espanha/epidemiologia , Estudos Retrospectivos , Infecções Estafilocócicas/microbiologiaRESUMO
OBJETIVO: Estimar la prevalencia de anticuerpos IgG frente a SARS-CoV-2 en profesionales sanitarios (PS) de un departamento sanitario (DS). MÉTODOS: Estudio de prevalencia. Se determinó la presencia de anticuerpos IgG frente a SARS-CoV-2 en los PS del DS. La determinación se realizó mediante la técnica de ELISA. El trabajo de campo se realizó del 24 de abril de 2020 al 8 de mayo de 2020. Se recogieron edad, sexo, estamento (facultativo, enfermería, etc.) y área de trabajo (atención primaria, urgencias, etc.). Se calculó la prevalencia de anticuerpos IgG frente a SARS-CoV-2 con su intervalo de confianza al 95% (IC95%). Para estudiar la asociación entre las características de los PS y la presencia de IgG se utilizó la prueba de la ji cuadrado y para cuantificar la magnitud de asociación se calculó la odds ratio (IC95%). RESULTADOS: De los 4.813 PS del DS participaron 4.179 (87,1%). De estos, el 73,3% (3.065) eran mujeres y el 26,7% (1.114) hombres. La prevalencia global de presencia de anticuerpos IgG frente a SARS-CoV-2 fue del 6,6% (IC95%: 5,8-7,3). Hubo diferencias estadísticamente significativas según estamento, oscilando del 8,7% (IC95%: 6,9-10,6) en facultativos al 3,2% (IC95%: 1,0-8,0) en otro personal no sanitario. El resto de características no se asociaron de forma significativa a la presencia de anticuerpos frente a SARS-CoV-2. CONCLUSIÓN: La frecuencia de infección por SARS-CoV-2 en PS es similar a la estimada para la población general en grandes ciudades en España, lo que orienta sobre la efectividad del programa de prevención y control de infecciones dirigido a los profesionales sanitarios en este DS
OBJECTIVE: Estimate IgG antibody prevalence against SARS-CoV-2 in healthcare personnel (HCP) of a healthcare department (HD). METHOD: Prevalence study. The presence of IgG antibodies against SARS-CoV-2 was determined in HCP of the HD. Enzyme linked immunosorbent assays (ELISA) tests were used. Field work took place from April 24, 2020 to May 8, 2020. The age, sex, occupation (physician, nurse, etc.) and the work area (Primary Care, Emergency Room, etc.) were gathered. The IgG antibody prevalence was then calculated with its 95% confidence interval (95%CI). To study the association between HCP characteristics and the presence IgG the Chi Square test was used, and to study the magnitude of association, the Odds Ratio (95%CI) was calculated. RESULTS: Of the 4813 HCP in the HD, 4179 (87,1%) participated. Of these, 73,3% (3065) were women and 26,7% (1114) men. The global prevalence of IgG antibodies against SARS-CoV-2 was 6,6% (95%CI: 5,8-7,3). There were statistically significant differences depending on the occupation, from 8,7% (95%CI: 6,9-10,6) on medics down to 3,2% (95%CI: 1,0-8,0) on personnel not associated with health care. The other characteristics did not associate significantly to antibody presence against SARS-CoV-2. CONCLUSION: The SARS-CoV-2 infection frequency in HCP is similar to the estimated in the general population for big cities in Spain. This highlights the effectiveness of the infection control and prevention programme in this healthcare department targeted at healthcare personnel
Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/imunologia , Pessoal de Saúde/estatística & dados numéricos , Estudos Soroepidemiológicos , Estudos Transversais , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Ensaio de Imunoadsorção Enzimática , Distribuição por Idade e Sexo , Prevalência , Fatores de Risco , Espanha/epidemiologiaRESUMO
INTRODUCCIÓN: El hombro doloroso es un problema médico común en Atención Primaria de salud y en el ámbito laboral. Puede producir una discapacidad funcional considerable y requerir de periodos de incapacidad temporal. OBJETIVOS: Describir las características de pacientes atendidos por patología no traumática del hombro, así como estudiar la asociación entre requerimientos ergonómicos y conocimientos preventivos del puesto de trabajo y el desarrollo de bajas laborales. MATERIAL Y MÉTODO: Estudio observacional transversal en una población de 345 pacientes en edad laboral que consultaron al médico de familia por dolor en el hombro en un año, pertenecientes a un centro de salud del Departamento de Salud de Alicante-Hospital General. Se utilizó un cuestionario con preguntas sobre conocimientos en prevención de riesgos laborales, requerimientos del puesto de trabajo y haber requerido o no periodos de incapacidad temporal derivada. Se realizó un análisis descriptivo y analítico. RESULTADOS: El 39,1% de los entrevistados refirieron periodos de baja laboral, calificándose el 87% como enfermedad común. El 51% refirió no tener información sobre los riesgos asociados a sus puestos de trabajo. Los requerimientos ergonómicos más frecuentes referidos por los encuestados fueron: posturas forzadas, alzar el brazo por encima del hombro, girar cuello-columna, y movimientos repetidos. Presentaron mayor probabilidad de baja las actividades relacionadas con construcción, agricultura, ganadería y pesca, conocer la existencia de evaluación de riesgos y/o plan de prevención y los requerimientos de alzar los brazos, golpear superficies, manejar cargas pesadas, y usar fuerza física. Conocer la existencia de un plan de prevención se mostró como factor de riesgo independiente (OR 4,2 [1,1-15,9]). CONCLUSIONES: Es importante abordar preventivamente los requerimientos ergonómicos del puesto así como conseguir mayores conocimientos de las estructuras preventivas para evitar el desarrollo de bajas laborales por hombro doloroso
INTRODUCTION: Painful shoulder is a common medical problem in Primary Health Care and at the workplace. It can cause a considerable functional disability and can require periods of sick leave. OBJECTIVES: To describe the characteristics of patients treated for non-traumatic diseases of the shoulder, as well as to know the association between ergonomic requirements and preventive knowledge about the workplace in the development of sickness absence. METHODS: Cross-sectional observational study in working age population of 345 patients who consulted their general practitioner throughout the year for shoulder pain, belonging to a health center from the Health Department of the Hospital General de Alicante. A questionnaire was used with questions about knowledge in occupational risk prevention, work requirements and whether or not temporary disability periods were required. A descriptive and analytical analysis was carried out. RESULTS: 39.1% of the interviewees reported periods of sick leave, qualified in 87% as a common disorder. 51% of them reported having no information about risks associated with their jobs. The most frequent ergonomic requirements referred by the respondents were: unnatural body posture, to raise the arm over the shoulder, to turn the neck-column, and to repeat movements. The probability of temporal disability was higher in those activities related to construction, agriculture, livestock and fisheries, people with knowledge of the existence of risk assessment and / or prevention plan, and the requirements of raising the arms, hitting surfaces, handling heavy loads, and using physical strength. To have knowledge about the existence of a prevention plan was shown as an independent risk factor (OR 4.2 [1.1-15.9]). CONCLUSIONS: It is important to preventively address the ergonomic requirements of the position as well as to gain greater knowledge of preventive structures in order to prevent the development of sick leave due to shoulder pain
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso , Ergonomia/estatística & dados numéricos , Ergonomia/normas , Lesões do Ombro/etiologia , Dor de Ombro/etiologia , Atenção Primária à Saúde , Licença Médica/estatística & dados numéricos , Estudos Transversais , Entrevistas como Assunto , Fatores de Risco , Fatores SocioeconômicosRESUMO
OBJETIVO: La vacunación anual contra la gripe es la medida más efectiva para prevenir la enfermedad y sus complicaciones. La efectividad vacunal (EV) varía de una temporada a otra, lo que obliga a reevaluarla anualmente. El objetivo de este trabajo fue estimar la efectividad preliminar de la vacuna de la gripe hasta la semana epidemiológica 4 de la temporada 2018/2019, en pacientes ingresados en un hospital de tercer nivel. MÉTODOS: Se realizó un estudio de casos y controles test negativos en el Hospital General Universitario de Alicante. Se consideró caso a los pacientes ingresados con gripe confirmada por laboratorio (RT-PCR positiva para cualquier virus influenza, en muestra clínica de aspirado nasofaríngeo) y como controles a aquellos con sospecha clínica de gripe y RT-PCR negativa, desde la semana 40 hasta la 4 de la temporada de gripe 2018/2019. Se calculó la cobertura de vacunación en los casos y en los controles, y la EV con su intervalo de confianza al 95% mediante la fórmula: EV= (1-Odds Ratio) x 100. RESULTADOS: Se incluyeron 524 pacientes: 58 casos y 466 controles. La EV global para la prevención de casos de gripe fue del 42,5 % (IC 95%: -17,1 a 71,8) y para mayores de 1 año de 63,7 % (IC 95%: 25,4 a 82,3). CONCLUSIONES: La vacuna de la gripe 2018-19 es efectiva para prevenir los casos de gripe en pacientes ingresados hasta la semana 4 de la temporada 2018-2019. Los resultados son preliminares y podrían variar, por lo que deberán reevaluarse al final de la temporada
OBJECTIVE: Annual flu vaccination is the most effective measure to prevent the disease and its complications. Vaccine effectiveness (EV) varies from season to season, requiring annual re-evaluation. The objective of this work was to estimate the preliminary effectiveness of the influenza vaccine until epidemiological week 4 of the 2018/2019 season, in patients admitted to a third level hospital. METHODS: The Test Negative Design (TDN) was carried out at the Hospital General Universitario de Alicante. Patients admitted with laboratory-confirmed influenza (RT-PCR positive for any influenza virus, in clinical sample of nasopharyngeal aspirate) and those with clinical suspicion of influenza and negative RT-PCR, from week 40 to week 4 of the 2018/2019 influenza season, were considered as controls. The vaccination coverage was calculated in the cases and in the controls, and the EV with its 95% confidence interval using the formula: EV = (1-Odds Ratio) x 100. RESULTS: We included 524 patients: 58 cases and 466 controls. The overall EV for prevention of influenza cases was 42.5 % (95% CI -17.1 to 71.8) and for those over 1 year of age 63.7 % (95% CI 25.4 to 82.3). CONCLUSIONS: The 2018-2019 influenza vaccine is effective in preventing influenza cases in patients admitted up to week 4 of the 2018-19 season. Results are preliminary and may vary and should be re-evaluated at the end of the season
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Vírus da Influenza A Subtipo H1N1 , Vírus da Influenza A Subtipo H3N2 , Vacinas contra Influenza , Influenza Humana/prevenção & controle , Estações do Ano , Estudos de Casos e Controles , Hospitalização , Influenza Humana/epidemiologia , Razão de Chances , Vigilância de Evento Sentinela , Resultado do Tratamento , Cobertura VacinalRESUMO
Introduction The aim of this project is to study several anatomical-radiological features of pituitary adenomas obtained from preoperative radiological images and to analyze their relationship with the extent of resection achieved through the endoscopic endonasal approach. The second objective was to create a prediction model of the extent of resection. Material and methods We retrospectively evaluated 105 patients. Tumor volume, Knosp grade, suprasellar-diaphragm coefficient and invasion of the posterior compartment have been analyzed. The extent of resection was assessed by analyzing the postoperative magnetic resonance. We created the predictive scale using statistically independent variables. Results When each of the variables has been studied individually, a statistically significant value of all of them is appreciated to obtain a complete resection. However, only the Knosp grade and the suprasellar-diaphragm coefficient had a statistically significant value as independent variables. The sum of the Odds Ratio obtained from the Knosp scale, and the suprasellar-diaphragm coefficient gives the probability of complete resection. A new set of cases was employed to validate the scale. Conclusions The cavernous sinus invasion and the newly designed suprasellar diaphragm coefficient are directly related to the extent of resection in pituitary adenoma surgery performed by a transellar endoscopic approach. Moreover, based on both radiologic factors, a predictive scale may predict the probability of complete resection in a series of patients (AU)
Introducción El objetivo principal de este proyecto es estudiar diversas variables anatomo-radiológicas de los adenomas hipofisarios obtenidas a partir de imágenes radiológicas preoperatorias y analizar su relación con el grado de resección logrado mediante el abordaje endoscopio endonasal. El segundo objetivo ha sido crear un modelo de predicción del grado de resección tumoral. Material y métodos Se ha evaluado retrospectivamente a 105 pacientes, analizando el volumen tumoral, el grado de Knosp, el coeficiente supraselar-diafragma y la invasión del compartimento posterior. El grado de resección se ha evaluado mediante el análisis de la resonancia magnética postoperatoria. Se ha creado la escala predictiva empleando variables estadísticamente independientes. Resultados Al estudiar cada una de las variables de forma individual, se aprecia un valor estadísticamente significativo en cada una de ellas para obtener una resección completa. Sin embargo, tan solo el grado de Knosp y el coeficiente supraselar-diafragma tuvieron un valor estadísticamente significativo como variables independientes. Empleando la suma de la odds ratio obtenida de la escala Knosp y el coeficiente supraselar-diafragma, se ha obtenido la probabilidad de resección completa. Se ha empleado un nuevo conjunto de casos para validar la escala. Conclusiones La invasión del seno cavernoso y el coeficiente supraselar-diafragma son variables que están directamente relacionadas con el grado de resección en la cirugía de adenoma hipofisario realizada mediante un abordaje endoscópico transellar. Además, basándose en ambos factores radiológicos, se ha creado una escala predictiva que permite predecir la probabilidad de resección completa en una serie de pacientes (AU)
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Adenoma/diagnóstico por imagem , Adenoma/cirurgia , Neoplasias Hipofisárias/diagnóstico por imagem , Neoplasias Hipofisárias/cirurgia , Cirurgia Endoscópica por Orifício Natural/métodos , Resultado do Tratamento , Estudos RetrospectivosRESUMO
Background. Bloodstream infections (BSIs) are associated with considerable morbidity and mortality among inpatients. The aim of this study was to evaluate the impact of a stewardship program on clinical and antimicrobial therapy-related outcomes in patients with bacteraemia. Methods. Single-centre, before-and-after quasi-experimental study in adult inpatients. Over 1 January 2013 to 31 June 2013 all patients aged 18 years or older with a bacteraemia (interven-tion group, N=200) were compared to a historical cohort (1 Janu-ary 2012 to 31 December 2012) (control group, N=200). Results. Following blood culture results and adjusting for potential confounders, the stewardship program was associated with more changes to antibiotic regimens (adjusted odds ratio [ORa]: 4.6, 95% CI 2.9, 7.4), more adjustments to antimicrobial therapy (ORa: 2.4, 95% CI 1.5, 3.8), and better source control in the first five days (ORa 1.6, 95% CI: 1.0, 2.7). In the subgroup that initially received inappropriate empiric treatment (n=138), the intervention was associated with more antibiotic changes (OR: 3.9, 95% CI: 1.8, 8.5) and a better choice of definitive antimicrobial therapy (OR 2.3 95% CI: 1.2, 4.6). There were also more antibiotic changes in the subgroups with both Gram-negative (OR: 2.8, 95% CI: 1.6, 4.9; n=217) and Gram-positive (OR: 4.6, 95% CI: 1.8, 9.9; n=135) bacteraemia among those receiving the intervention, while the Gram-positive subgroup also received more appropriate definitive antimicrobial therapy (OR: 3.9, 95% CI: 1.8, 8.8). Conclusion. The stewardship program improved treatment of patients with bacteraemia and appropriateness of therapy (AU)
Introducción. Las bacteriemias están asociadas con una elevada morbilidad y mortalidad en pacientes hospitalizados. El objetivo del estudio fue evaluar el impacto de un programa de intervención clínica y de terapia antimicrobiana en pacientes con bacteriemia. Material. Estudio en un centro tipo cuasi-experimental pre y post-intervención en pacientes adultos hospitalizados. Desde 1 enero 2013 a 31 junio 2013, todos los pacientes mayores de 18 años en los que se identificaba una bacteriemia (grupo de intervención) se compararon con una cohorte histórica de bacteriemia (1 enero 2012 a 31 diciembre 2012) (grupo control). Resultados. Se incluyeron 200 pacientes en cada grupo. Después de ajustar por los posibles factores de confusión y tras conocer el resultado de los hemocultivos, el grupo de intervención tuvo más cambios de antibióticos (Odds ratio ajustada [ORa]: 4,6, intervalo de confianza [IC] 95%: 2,9-7,4), mayor adecuación del tratamiento antibiótico (ORa: 2,4, IC 95%: 1,5-3,8) y mayor control de la infección en los primeros cinco días (ORa 1,6, IC 95%: 1,0-2,7). En el subgrupo de pacientes que seguían un tratamiento inadecuado cuando se identificó el microorganismo en el hemocultivo (n =138), la intervención se asoció con un mayor cambio de antibiótico (OR: 3,9, IC 95%: 1,8-8,5) y una mejor elección final del antibiótico (OR: 2.3; IC 95%: 1.2-4.6). En el subgrupo de bacteriemia por gramnegativos (n=217), el programa de intervención en bacteriemia se asoció con un mayor cambio de antibiótico (OR: 2,8; IC 95%: 1,6-4,9) y en el subgrupo de bacteriemia por microorganismos grampositivos (n=135), el programa de intervención indujo un mayor cambio en el uso de antibióticos (OR: 4,6, IC 95%: 1,8-9,9) y una mejor elección final del tratamiento (OR: 3,9; 95% CI: 1,8-8,8). Conclusión. El programa de intervención en bacteriemia mejoró el tratamiento de los pacientes con bacteriemia y la adecuación del mismo (AU)